Amneal Pharmaceuticals, Inc. (AMRX) on GreekSoup https://greeksoup.ai/stocks/us/amrx/ Every dated entry in the public record on Amneal Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Amneal Pharmaceuticals, Inc. filed 8-K/A: 8-k/ahttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-10-23:763a38488cFri, 23 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: short interest 14,067,810 shares at the 15 October 2026 settlement, 3.69 days to coverhttps://greeksoup.ai/stocks/us/amrx/short-interest/us:AMRX:short-interest:2026-10-15:70fd9250f8Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: short interest 11,278,967 shares at the 30 September 2026 settlement, 3.06 days to coverhttps://greeksoup.ai/stocks/us/amrx/short-interest/us:AMRX:short-interest:2026-09-30:828054eccbWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: short interest 11,289,778 shares at the 15 September 2026 settlement, 6.64 days to coverhttps://greeksoup.ai/stocks/us/amrx/short-interest/us:AMRX:short-interest:2026-09-15:62bced4b64Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. filed S-3ASR: s-3asrhttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-09-03:5b44aa6692Thu, 03 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: short interest 10,571,834 shares at the 31 August 2026 settlement, 7.41 days to coverhttps://greeksoup.ai/stocks/us/amrx/short-interest/us:AMRX:short-interest:2026-08-31:157333baf1Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Kiely John (Director) sold 50,000 shares at $17.64 on 13 August 2026, $882,000https://greeksoup.ai/stocks/us/amrx/insiders/us:AMRX:insider:2026-08-14:8541f51cd7Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: short interest 9,514,369 shares at the 14 August 2026 settlement, 4.89 days to coverhttps://greeksoup.ai/stocks/us/amrx/short-interest/us:AMRX:short-interest:2026-08-14:e6a2de30e8Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Form 144, JOHN KIELY plans to sell 50,000 shares worth $879,714 around 13 August 2026https://greeksoup.ai/stocks/us/amrx/planned-sales/us:AMRX:planned-sale:2026-08-13:a7d7c9e83bThu, 13 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Shah Nikita (Executive Vice President) sold 146,403 shares at $17.51 on 12 August 2026, $2.6 millionhttps://greeksoup.ai/stocks/us/amrx/insiders/us:AMRX:insider:2026-08-13:0b281bbd03Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Daly Jason B. (EVP, Chief Legal Officer) sold 210,000 shares at $17.40 on 12 August 2026, $3.7 millionhttps://greeksoup.ai/stocks/us/amrx/insiders/us:AMRX:insider:2026-08-13:415e034aadThu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Daly Jason B. (EVP, Chief Legal Officer) sold 6,613 shares at $17.70 on 11 August 2026, $117,050https://greeksoup.ai/stocks/us/amrx/insiders/us:AMRX:insider:2026-08-13:c99a90802bThu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Form 144, NIKITA SHAH plans to sell 146,403 shares worth $2.6 million around 12 August 2026https://greeksoup.ai/stocks/us/amrx/planned-sales/us:AMRX:planned-sale:2026-08-12:452666bf4bWed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Form 144, JASON DALY plans to sell 210,000 shares worth $3.6 million around 11 August 2026https://greeksoup.ai/stocks/us/amrx/planned-sales/us:AMRX:planned-sale:2026-08-12:8b22920bfcWed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Schedule 13D/A filed by Tushar Patel, 17.6% of the classhttps://greeksoup.ai/stocks/us/amrx/holders/us:AMRX:schedule-13:2026-08-12:6152aadd17Wed, 12 Aug 2026 00:00:00 +0000Schedule 13D/13GThis Amendment No. 6 to Schedule 13D (this "Amendment No. 6") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 6, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 6 shall have the meanings set forth in the Schedule 13D.

Schedule 13D/13G. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Schedule 13D/A filed by Chirag Patel, 8.4% of the classhttps://greeksoup.ai/stocks/us/amrx/holders/us:AMRX:schedule-13:2026-08-12:c07055407dWed, 12 Aug 2026 00:00:00 +0000Schedule 13D/13GThis Amendment No. 7 to Schedule 13D (this "Amendment No. 7") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 7, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 7 shall have the meanings set forth in the Schedule 13D.

Schedule 13D/13G. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Schedule 13D/A filed by Chintu Patel, 9.4% of the classhttps://greeksoup.ai/stocks/us/amrx/holders/us:AMRX:schedule-13:2026-08-12:004f05d9adWed, 12 Aug 2026 00:00:00 +0000Schedule 13D/13GThis Amendment No. 5 to Schedule 13D (this "Amendment No. 5") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 5, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 5 shall have the meanings set forth in the Schedule 13D.

Schedule 13D/13G. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: Form 144, BUCHI J KEVIN plans to sell 168,573 shares worth $2.9 million around 11 August 2026https://greeksoup.ai/stocks/us/amrx/planned-sales/us:AMRX:planned-sale:2026-08-11:5dfa86dc1bTue, 11 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. filed 8-K: material agreement, acquisition or disposition completed, new financial obligation, unregistered sale of equity, regulation fd disclosurehttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-08-10:7fb343aab0Mon, 10 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. Q2 FY2026 results: revenue $796 million, net income $58 millionhttps://greeksoup.ai/stocks/us/amrx/results/fy2026-q2/us:AMRX:result:2026-08-06:de824acf3fThu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-08-06:ddcc7fe485Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. filed 8-K: material agreementhttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-08-03:75cd87ba6dMon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. filed 8-K: shareholder votehttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-07-31:bddf028948Fri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc.: short interest 8,320,187 shares at the 31 July 2026 settlement, 4.57 days to coverhttps://greeksoup.ai/stocks/us/amrx/short-interest/us:AMRX:short-interest:2026-07-31:5d5b61d167Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. filed 8-K: results of operations, regulation fd disclosurehttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-07-30:f393d7c864Thu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Amneal Pharmaceuticals, Inc. filed DEFA14A: defa14ahttps://greeksoup.ai/stocks/us/amrx/filings/us:AMRX:filing:2026-07-30:14c11635fdThu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>